REGISTERED NUMBER: 07557627 (England and Wales)

Unaudited Financial Statements For The Year Ended 31 March 2025

for

Ultra Biotecs Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr M R Snowball

Mr S M Gordon

Mr P E Barr

REGISTERED OFFICE:

7 Billing Road

Northampton

NORTHAMPTONSHIRE

NN1 5AN

REGISTERED NUMBER:

07557627 (England and Wales)

ACCOUNTANTS:

Cochran, Harris & Clarke Ltd

7 Billing Road

Northampton

NORTHAMPTONSHIRE

NN1 5AN

FIXED ASSETS

Intangible assets

4

48,808

62,952

Tangible assets

5

772,974

775,552

821,782

838,504

CURRENT ASSETS

Debtors

6

63,676

5,400

Cash at bank and in hand

209,276

352,078

272,952

357,478

CREDITORS

Amounts falling due within one year

7

385,370

406,758

NET CURRENT LIABILITIES

(112,418

)

(49,280

)

TOTAL ASSETS LESS CURRENT LIABILITIES

709,364

789,224

CREDITORS

Amounts falling due after more than one year

8

-

158,420

NET ASSETS

709,364

630,804

CAPITAL AND RESERVES

Called up share capital

26,004

26,004

Share premium

2,101,966

2,101,966

Retained earnings

(1,418,606

)

(1,497,166

)

SHAREHOLDERS' FUNDS

709,364

630,804

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 October 2025 and were signed on its behalf by:

Mr P E Barr - Director

1.	STATUTORY INFORMATION

Ultra Biotecs Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis. This is dependant upon the continuing support of the shareholders.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover from operating leases granted to customers is accounted for on a straight line basis over the period of the lease

Intangible assets

Patents purchased by the company are amortised individually over their anticipated economic life. The anticipated economic life of the existing purchased patents is five years.

Applications for patents resulting from research and development expenditure is written off unless the patent has a readily ascertainable market value in accordance with accounting standard FRS10.

The company has capitalised costs associated with developing patents. The costs are being written off over ten years commencing from January 2019.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost, 20% on cost, 10% on cost, Over the length of time of the lease and Straight line over 3 years

Financial instruments

The company only enters into basic financial instruments that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties and loans to related parties.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit and loss.

Financial assets and liabilities are offset and the ent amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Research and development

With the exception of costs incurred in respect of the development of prototype plant, expenditure on research and development is written off in the year in which it is incurred

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 6 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

At 1 April 2024

and 31 March 2025

154,821

AMORTISATION

At 1 April 2024

91,869

Charge for year

14,144

At 31 March 2025

106,013

NET BOOK VALUE

At 31 March 2025

48,808

At 31 March 2024

62,952

5.	TANGIBLE FIXED ASSETS

Plant and

Computer

Prototypes

machinery

equipment

Totals

£

£

£

£

COST

At 1 April 2024

1,411,169

160,747

5,434

1,577,350

Additions

182,579

-

6,310

188,889

At 31 March 2025

1,593,748

160,747

11,744

1,766,239

DEPRECIATION

At 1 April 2024

662,336

135,010

4,452

801,798

Charge for year

186,284

4,350

833

191,467

At 31 March 2025

848,620

139,360

5,285

993,265

NET BOOK VALUE

At 31 March 2025

745,128

21,387

6,459

772,974

At 31 March 2024

748,833

25,737

982

775,552

Tangible fixed assets include assets leased to customers. The cost of leased assets amounts to £117,247 (2024: £117,247) with a net book value of £nil (2024: £nil). Depreciation charged on assets leased to customers for the period was £nil (2024: £9,841).

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

-

5,400

Other debtors

63,676

-

63,676

5,400

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

7,028

4,587

Taxation and social security

39,430

28,117

Other creditors

338,912

374,054

385,370

406,758

Other creditors includes an amount of £89,722 (2024: £89,444) in respect of deferred income. The deferred income relates to income from operating leases that extend beyond the accounting period.

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Other creditors

-

158,420

9.	SECURED DEBTS

The following secured debts are included within creditors:

2025

2024

£

£

Other loans

218,953

410,927

These amounts are secured by a fixed and floating charge over all property or undertaking of the company.

10.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

M R Snowball and P E Barr have advanced monies to the company. At the balance sheet date the amount due to M R Snowball is £213 (2024: £213).and to P E Barr is £98 (2024: £98)